Locally Advanced, Resectable
1 clinical trials · Condition
◉ Watch Locally Advanced, Resectable
| Record | Firm | Date |
|---|---|---|
| Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (NCT07374003) | Sun Yat-sen University | 2025-12-17 |
Track Locally Advanced, Resectable automatically
Every clearance here is in the API, with alerts when new ones post.